Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1956-2018Class II

MagNA Pure 24 System, GMMI: 07290519001

Roche Molecular Systems Inc / initiated 2018-05-02 / Terminated / root cause: software

Roche Molecular Systems, Inc. began a recall of MagNA Pure 24 System, GMMI: 07290519001 Product Usage: The MagNA Pure 24 System is a fully automated clinical sample extractor. It extracts nucleic acids from... on . FDA classified it as Class II and gives the reason as "Cross-contamination of samples has been reported when running the existing protocol on the system with the rack-based purification run". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-1956-2018
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Roche Molecular Systems Inc
Product
MagNA Pure 24 System, GMMI: 07290519001 Product Usage: The MagNA Pure 24 System is a fully automated clinical sample extractor. It extracts nucleic acids from various sample types, sample tubes, and volume inputs for multiple downstream applications. The main features of the system are : Scalable purification of 1 to 24 samples Primary/secondary tube handling Inventory and sample management via barcodes Efficient order management via host The MagNA Pure 24 System offers 4 run types: Purification (rack) run Purification (cartridge) run Post Elution run Sample transfer run
Product code
JJH Clinical Sample Concentrator
Reason for recall
Cross-contamination of samples has been reported when running the existing protocol on the system with the rack-based purification run.
Root cause tag
software
FDA root cause
Software in the Use Environment
Action
Customers were notified of the field action by letter on 4/27/18. The letter included the following required actions: " If you used the MagNA Pure 24 Pathogen 200 and/or Pathogen 1000 protocols to extract nucleic acids for an assay for a chronic infectious disease (e.g., Hepatitis C Virus), then suspected false positives should be evaluated further following local procedures and retested as necessary. " Complete the attached fax form and fax it to 1-844-861-6232 or email it to [email protected]. " File this Urgent Medical Device Correction (UMDC) for future reference.
Quantity in commerce
163 units
Distribution
Worldwide Distribution - US Nationwide in the states of: CA, GA, HI, IN, MD, ME, MI, MN, NC, NY, PA, VI, and WI. The products were distributed to the following foreign countries: Austria, Belgium, Brazil, Chile, China, Columbia, Costa Rica, Czech Republic, Denmark, France, Germany, Guatemala, Hong Kong, Hungary, India, Israel, Italy, Japan, Mexico, Netherlands, Norway, Poland, Singapore, Slovenia, South Africa, South Korea, Spain, Switzerland, Taiwan, UAE, United Kingdom, Vietnam.
Product codes and lots
Device Identifier: 07613336106174

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1956-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1956-2018Class IITerminatedVoluntary: Firm initiated